Michael Mao, M.D. retweeted
Our senior fellows don’t just attend #KidneyWeek—they present their work, learn from leaders in nephrology, build meaningful connections, and bring that knowledge back to teach all of us at Mayo Clinic Florida.
That’s the kind of growth we want fellowship to create. 💙🫘
Michael Mao, M.D. retweeted
From posters and podiums to mentorship, reunions, and new connections—#KidneyWeek 2026 in Denver reminded us that nephrology is as much about the people as the science.
Proud to represent Mayo Clinic Florida and our incredible nephrology community! 💙
#ASN2026 #Nephrology 1/4
Hooray to Dr. Ritchie. Published!
sciencedirect.com/science/ar…
Michael Mao, M.D. retweeted
When you’re rounding with Dr. Baker and the team and realize the most pup-ular consultant in the hospital has joined you… 🐶🩺
Our Mayo Caring Canines even come credentialed: “Dogtor.”
No comment yet on their approach to AKI. 🫘🐾
#Nephrology #Mayo #MedEd #FellowshipLife
Michael Mao, M.D. retweeted
The inaugural @MayoClinicNeph Glomerular Diseases & Kidney Pathology course is off to an exciting start! With over 1500 patients in our GN program and >500 new glomerular consults per year, as well as >9000 kidney biopsies read by our kidney pathology colleagues per year…
Michael Mao, M.D. retweeted
A new space for our trainees at Mayo Clinic Florida! ✨🩺
Freshly renovated, comfortable, and designed to be a place to work, connect, recharge—and relax between the busy moments. ☕️📚
Because a great learning environment is about more than just the classroom.
#Nephrology
Michael Mao, M.D. retweeted
Some of our nephrology consultants (attendings) at Mayo Clinic Florida catching up, collaborating, and getting ready to teach.
Great education starts with colleagues who enjoy learning from—and teaching—each other. 🫘📚
#Nephrology #MedEd #Teamwork #Kidney
Michael Mao, M.D. retweeted
📚🙏🏻😊 Excited to share our newly published Perspective, now available ahead of print in Kidney360! @asnpublications
“Artificial Intelligence in Nephrology Practice: Practical Pathways to Improve Efficiency”
🔗 Read here: ovid.com/jnls/kidney360/full… 
In this Perspective, we explore practical opportunities to integrate AI into everyday nephrology workflows.
Our focus highlights how we can:
🔹 Improve Efficiency: Utilizing AI to streamline routine clinical tasks and significantly reduce administrative burden
🔹 Support Clinicians: Designing practical pathways that serve as a force multiplier for kidney care professionals
🔹 Maintain Human Oversight: Ensuring that AI implementation remains responsible, with clinicians firmly at the center of verification and decision-making
Authors: Noppawit Aiumtrakul, Dr. Charat Thongprayoon, and Wisit Cheungpasitporn
A sincere thank you to my fantastic co-authors, Dr. Noppawit Aiumtrakul (@NoppawitMD) and Dr. Charat Thongprayoon, for this great collaboration! 🙏🏻 Thank you as well to @asnpublications for sharing this piece.
🔓 Read the full article here:
🔗 DOI: 10.34067/KID.0000001424
Wisit Cheungpasitporn, MD, FACP, FASN, FAST
Professor of Medicine, Division of Nephrology and Hypertension
AI Course Director, Mayo Clinic Alix School of Medicine
Mayo Clinic, Minnesota
#ArtificialIntelligence #Nephrology #Kidney360 #DigitalHealth #ClinicalAI #MayoClinic @MayoClinicNeph
Traveling in style… 😎⛳️🛺
When your ride to the outpatient dialysis unit is a golf cart (nephrologist chauffeur not always included). Only at Mayo Clinic Florida!
Just another day of nephrology rounds at @MayoClinic Florida. 🫘🩺
#Nephrology #Dialysis #Kidney #MedEd
Michael Mao, M.D. retweeted
🩸 Casts. Cells. Crystals. Clues. 🔬
There’s no substitute for learning #UrineMicroscopy in real time at the microscope.
Hands-on nephrology education with Dr. Trautman & Dr. Hanna at @MayoClinic—turning urine sediment into clinical insight.
#Nephrology #MedEd
Michael Mao, M.D. retweeted
😊🙏🏻📢 Happy to see @asnpublications highlight our article in ASN Kidney News: “AI in Kidney Care Is Ready. Is Reimbursement?”
Read the article: kidneynews.org/view/journals…
AI is finding applications across kidney care, from predicting CKD progression to supporting transplant care. As these tools enter practice, reimbursement raises a question: What value must kidney AI demonstrate to earn a sustainable place in care?
In the article, Charat Thongprayoon, Ambarish Athavale, and I discuss four priorities: measurable patient benefit, integration into clinical workflows, safety and clinician oversight, and viable reimbursement pathways.
Grateful to Charat and Ambarish for this collaboration. What evidence would persuade your health system to adopt a kidney AI tool? I would welcome your thoughts. 👇 @dr_athavale
Wisit Cheungpasitporn, MD, FACP, FASN, FAST
Professor of Medicine, Division of Nephrology and Hypertension
AI Course Director, Mayo Clinic Alix School of Medicine
#ASNKidneyNews #Nephrology #KidneyCare #ClinicalAI #HealthPolicy
AI is rapidly transforming kidney care, from predicting CKD progression to optimizing transplantation. But as adoption grows, an important question remains: Are reimbursement models ready to support its use? kidney.pub/KN1809-18 #ASNKidneyNews
@wisit661
Michael Mao, M.D. retweeted
Truly honored and privileged to present the Helmut Rennke lectureship at GlomCon Hawaii.
A Mentor, a Teacher can change the life of a student and I owe a debt of gratitude to Dr. Rennke for what I have learned and achieved.
I spoke on MPGN, the journey, and how it has changed from a pattern based diagnosis to an etiology based diagnosis and its impact on patient care and management.
@GlomCon @MayoClinicNeph @MayoClinicPath
Michael Mao, M.D. retweeted
Excited for the launch of our new Nephrology–Rheumatology Joint Clinic at Mayo Clinic Florida led by Dr. Shane Bobart!
This clinic offers collaborative, multidisciplinary, state-of-the-art care for complex kidney and autoimmune diseases through collaboration in real time.
Michael Mao, M.D. retweeted
🙂🙏🏻 Honored to share our latest publication in @ASNKidney ASN Kidney News! 🗞️✨
“Ambient AI Scribes: Evidence Arrives and What It Means for Kidney Care”
🔗 Read the full article here: kidneynews.org/view/journals…
Ambient AI scribes are rapidly moving from concept to real-world implementation in clinical care. In our new piece, we explore the emerging evidence, the immense potential, and the critical guardrails needed as we adopt this technology.
Here are a few key takeaways:
🔹 The Nephrology Advantage: In a specialty defined by complex longitudinal data, intricate medication reconciliations, and high documentation demands, these tools can be particularly impactful.
🔹 Beyond Efficiency: The real opportunity lies in improving clinical focus, enhancing direct patient communication, and strengthening continuity of care.
🔹 Thoughtful Implementation is Key: Success requires prioritizing accuracy, safety, governance, and seamless workflow integration, while reinforcing the absolute necessity of physician oversight and validation.
A profound shift is underway: from documentation as a burden ➡️ to AI-enabled cognitive support embedded directly into care delivery.
I, Wisit Cheungpasitporn, am incredibly grateful to contribute to this important conversation on responsibly transforming kidney care alongside my outstanding co-authors, Dr. Jing Miao and Dr. Charat Thongprayoon. 🙏🏻 @jingmiao2019 @MayoClinicNeph
🔗 Read the full article here: kidneynews.org/view/journals…
Special thanks to Dr. @kdjhaveri
Wisit Cheungpasitporn, MD, FACP, FASN, FAST
#AIinMedicine #Nephrology #KidneyCare #DigitalHealth #AmbientAI #ClinicalDocumentation #PhysicianBurnout #FutureOfMedicine #MayoClinic #ASNKidneyNews
Michael Mao, M.D. retweeted
Fearfully and wonderfully made.
The intricate anatomy of the cortex of kidney displayed with imaging mass cytometry. @Renalpathsoc @MayoClinicPath @MayoTransplant @MayoClinicNeph
@TheUSCAP @ISNWCN
Michael Mao, M.D. retweeted
🔦✅Fibrillary Glomerulonephritis (FGN) : Classic Diagnostic Features
Renal biopsy: Mesangial expansion + irregular capillary wall thickening with PAS-positive, silver-negative deposits. Congo red negative.
🔬 Immunofluorescence (IF) (classic polytypic pattern):
- Bright IgG (often IgG4 > IgG1, polyclonal)
- Both κ and λ light chains positive (no restriction)
- C3 positive (often 2–3+)
- Variable IgM/IgA (usually weak/negative)
⚡ Electron Microscopy (EM) : pathognomonic:
- Randomly oriented, straight, non-branching fibrils (mean ~18–22 nm diameter, range 12–24 nm)
- No hollow centers (distinguishes from immunotactoid GN)
- Deposits in mesangium, GBM, subendothelial ± subepithelial spaces
🧬 DNAJB9 immunohistochemistry:
- Strong, diffuse glomerular positivity (mesangial + capillary wall) , highly sensitive & specific (>95%) for FGN
- Now considered the gold-standard confirmatory marker (revolutionized diagnosis even when EM is unavailable)
🔦✅Monotypic (monoclonal-appearing) FGN:
- Rare subset (~3–11% of cases)
- Shows light-chain restriction (e.g., lambda or kappa) ± IgG subclass restriction (often IgG1)
- Most DNAJB9+ monotypic cases do NOT have detectable circulating monoclonal gammopathy or underlying plasma cell/lymphoproliferative disorder (paraffin IF often needed to confirm true monoclonality)
- Still evaluate for paraprotein-related disease (SPEP/UPEP, bone marrow, etc.) in monotypic cases @MayoClinicNeph
Happy thank a resident/fellow week!
A sincere thank you to each of our future colleagues. Your hard work behind the scenes, teamwork, and professionalism make a meaningful difference every day. It is a privilege and I’m grateful to learn with you as we work to improve lives.
Michael Mao, M.D. retweeted
😃🙏🏻 Please join us for AI in Nephrology: A Hands-on Primer Workshop📍 New York Academy of Medicine | New York, New York
🗓 March 16–17, 2026
asn-online.org/ai
There are abstract submission opportunities as well as American Society of Nephrology @ASNKidney grant opportunities available for eligible participants.
This is a hands-on, clinically grounded AI workshop designed with kidney care as the central use case throughout the program.
📝🤝
📍This workshop is intentionally multidisciplinary.
No prior AI experience is required. Sessions are structured to engage participants across experience levels, from first exposure to early implementation.
Call for Abstracts
Fellows, residents, trainees, junior faculty, and graduate students are strongly encouraged to submit abstracts, including:
Original research
Applied case studies
Implementation experiences involving AI, machine learning, or data science
🏆 Top three abstracts will receive $300 travel grants
🗓 Abstract deadline: Wednesday, February 11, 2026
Registration
$75 for fellows and graduate students
$150 for all other participants
Space is limited. Early registration is encouraged.
🔗 Meeting details, abstract submission, travel grants, and registration:
asn-online.org/ai
What Makes This Workshop Different
Kidney care is the core use case, not an afterthought
Fully interactive, hands-on sessions using real-world nephrology scenarios
Simulation-based exercises focused on clinical workflows and implementation challenges
Every participant actively works through exercises (personal computer required)
Learning Objectives
Participants will be able to:
Describe core AI concepts and their relevance to healthcare delivery
Demonstrate practical applications of AI in kidney care settings
Identify personal competencies and gaps related to responsible AI use through guided tutorials
These initiatives reflect ASN’s commitment to building responsible, clinically grounded, and workforce-ready AI literacy across nephrology. I strongly encourage fellows and trainees to take advantage of this unique learning opportunity and to share this within your programs.
Hotel Accommodations
There is no designated conference hotel or room block to allow attendees flexibility in choosing accommodations that fit their preferences. A list of recommended hotels is available.
Questions regarding logistics can be directed to Crystal Johnson, Director of Communications and Events, Renal Research Institute (RRI)
📧 [email protected]
I, Wisit Cheungpasitporn will personally be joining and am honored to speak and discuss hands-on AI in nephrology and kidney care education together.
See you everyone.
— Wisit Cheungpasitporn, MD
ASN AI Steering Committee
Michael Mao, M.D. retweeted
So proud of our incredible Mayo Nephrology fellows. Every day they put patients first, lead with compassion, and commit to excellence through hard work and education.








































